📌 Key Takeaways
- Topic: Is Silicon Dioxide Safe? What Science and Regulators Say
- Keywords: polysilicon
- Published: 2026-11-20 09:17:30
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Silica and Sodium Hydroxide Reaction: Equation, Products and Applications
- What Is Hydrated Silica? Uses in Toothpaste, Cosmetics and Food Explained
- Silica Distributor vs Manufacturer: Which Is Better for Your Purchase?
- What Is Silica? A Simple Explanation of Silica, Its Forms and Uses
- The drug loading capacity and the drug release profile for each drug loaded by the solvent immersion approach.
- What Is Sodium Silicate? Properties, Uses and Relationship to Silica
- 42. Ortega E., Ruiz M.A., Peralta S., Russo G., Morales M.E. Improvement of mesoporous silica nanoparticles: A new approach in the administration of NSAIDS. J. Drug Deliv. Sci. Technol. 2020;58:101833. doi: 10.1016/j.jddst.2020.101833. [ DOI ] [ Google Scholar ]
What Is Fused Quartz? Properties, Manufacturing Process and Applications
What is silica (SiO₂)?
ultra pure silica
What is the difference between fumed silica and precipitated silica?
silica gel desiccant Tamás Sovány
What drives silica raw material prices?
CMP slurry silica Tablets are the most used solid dosage form because of their numerous perks. They are characterized by excellent physical and chemical stability, high patient compliance, and productive economic production [ 92 ]. The incorporation of silica nanocarriers in tablet production presents a modern and innovative solution to diverse hurdles, boosting both the manufacturing process and therapeutic effectiveness. One of the considerable benefits of mesoporous silica carriers is their ability to stabilize the API in an amorphous state, which greatly improves its solubility [ 30, 39, 42, 43, 92 ]. This enhancement brings about a considerable increase in the dissolution rate of tablets, thereby improving bioavailability and resulting in more effective therapy [ 30, 39, 42, 92 ]. Furthermore, nanocarriers can effectively mask the bitter taste and unpleasant odor of the API, potentially further boosting patient compliance [ 42, 93 ]. Zhang et al. observed a considerable improvement in oral bioavailability with Telmisartan-loaded MSN carriers in vivo absorption studies conducted on dogs [ 24 ]. This MSN-containing tablet formulation was compared to commercially available tablets, with notable improvements attributed chiefly to the boosted permeability and solubility provided by the nanocarriers [ 24 ]. Moreover, the physical and chemical stability of the API may also improve, which is especially advantageous for sensitive molecules [ 39, 92 ].
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.